DOYLE THOMAS JAMES — SEC Form 4 filings
SEC reporting owner CIK 1910331. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-27.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-31 to 2026-01-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 5 filings — 23,489 shares, $231,984 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 4,539 shares @ $11.18 ($50,732) in Kura Oncology, Inc., filed 2025-11-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | 7 | — | 14 legs · 23,489 sh · $231,984 | 7 |
Form 4 filings — DOYLE THOMAS JAMES
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-27 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 2,226 @ $8.46 · Sale (S): 1,114 @ $8.46 · Sale (S): 695 @ $8.46 · Sale (S): 2,226 @ $8.46 · Sale (S): 881 @ $8.46 | EDGAR |
| 2026-01-06 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 21,250 @ $0 · Grant/award (A): 42,500 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 24,967 @ $0 · Sale (S): 4,539 @ $11.18 | EDGAR |
| 2025-09-29 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 24,966 @ $0 · Sale (S): 4,541 @ $8.94 | EDGAR |
| 2025-01-28 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 2,241 @ $7.87 · Sale (S): 887 @ $7.87 · Sale (S): 699 @ $7.87 · Sale (S): 1,122 @ $7.87 | EDGAR |
| 2025-01-06 | 4 | Kura Oncology, Inc. (KURA) | Grant/award (A): 21,250 @ $0 · Grant/award (A): 21,250 @ $0 · Grant/award (A): 42,500 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Kura Oncology, Inc. (KURA) | Sale (S): 594 @ $17.80 · Sale (S): 761 @ $17.80 · Sale (S): 963 @ $17.80 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1910331 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →